It has been reported that loss of certain tight junctional molecules, such as ZO-1, ZO-2, and occludin are frequently seen in clinical tumours and the loss of these TJ molecules is associated with the aggressiveness of tumours [26-29]. The gene discussed is TJP1; the disease is neoplasm.